SINGAPORE (Apr 14): OCBC Investment Research is keeping its “buy” recommendation on Frasers Centrepoint Trust (FCT), but with a lowered target price of $2.23 from $3.07 previously.

Although FCT has been delivering positive DPU growth every year since it listed in July 2006, with a CAGR of 5.5%, this track record may be broken in FY20 due to unprecedented measures introduced by the Singapore government to tackle the Covid-19 impact.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply


Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook